Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.74
USD |
NASDAQ |
Jan 22, 16:00
Mirati Therapeutics Profit Margin (Quarterly): -987.2% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 17.96% |
| Karuna Therapeutics Inc (DELISTED) | -- |
| Puma Biotechnology, Inc. | 16.24% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.82% |
| Return on Assets | -64.99% |
| Return on Invested Capital | -77.82% |
| Gross Profit Margin (Quarterly) | 89.71% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -483.2% |